C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids

More topics under "C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids" (173,078)
C07H 1 - Processes for the preparation of sugar derivatives (12,374)
C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722)
C07H 13 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids (4,753)
C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
C07H 23 - Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin b12 (1,716)
C07H 3 - Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms (5,762)
C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
C07H 99 - Subject matter not provided for in other groups of this subclass (52)

Patents for C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids (1,168)
01/2002
01/02/2002	CN1329617A Hygromycin A derivatives as antibacterial agents
12/2001
12/20/2001	WO2000066602A9 3-deoxy-desmycosin derivatives and process for their preparation
12/13/2001	WO2001094368A1 2-aminocarbonyl-9h-purine derivatives
12/13/2001	WO2001094362A2 Haplotypes of the acp2 gene
12/06/2001	WO2001092282A2 Methods and compositions for treating flaviviruses and pestiviruses
12/04/2001	CA2237730C Method and compositions for the synthesis of dioxolane nucleosides with .beta.-configuration
11/2001
11/29/2001	WO2001090124A2 Haplotypes of the gpr31 gene
11/29/2001	WO2001090118A2 Haplotypes of the edn2 gene
11/29/2001	WO2001090115A2 Haplotypes of the cdk4 gene
11/07/2001	EP1150991A2 Compositions for treating inflammatory response
11/06/2001	US6313100 Antibacterial, antiprotozoa agents
10/2001
10/31/2001	EP1149109A1 Method for deprotecting oligonucleotides
10/30/2001	US6310200 Comprising carboxylation of an oligosaccharide using a di-tert-alkyl nitroxyl free radical as catalyst and 1,3-dibromo or -chloro-5,5-di-methylhydantoin as oxidizers at a ph of 7-1o; efficiency
10/25/2001	WO2001079244A1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
10/11/2001	WO2001075164A2 Rna sequence-specific mediators of rna interference
10/11/2001	CA2404890A1 Rna sequence-specific mediators of rna interference
10/04/2001	WO2001072288A2 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
09/2001
09/26/2001	EP1135400A1 Hygromycin a derivatives as antibacterial agents
09/19/2001	CN1313861A 2-(purin-9-YL)-tetrahydrofuran-3,4-diolderivatives
09/18/2001	US6291649 Anti-bodies binding adhesin-derived antigens
09/18/2001	US6290969 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/2001
08/29/2001	EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer
08/29/2001	CN1309970A Application of uridine phosphorylase inhibitor and composition containing the same
08/22/2001	EP1124565A1 Beta-l-2'-deoxy-nucleosides for the treatment of hiv infection
08/08/2001	CN1307583A Method for preparing aloin by extraction
08/01/2001	EP0763133B1 Method for detecting a target nucleic acid
07/2001
07/19/2001	WO2001051059A1 Processes for preparing clarithromycin polymorphs
07/19/2001	CA2397092A1 Processes for preparing clarithromycin polymorphs
07/03/2001	US6255477 Made by forming a sol form alcohol and metal alkoxides, contacting with magnetic cores, spray drying to enclose cores in gel layer, heating to form a coating of nonporous glass and recovering individually free magnetic glass particles
06/2001
06/13/2001	CN1299367A 2''-deoxy hygromycin derivatives
06/13/2001	CN1299365A Hygromycin A derivatives
06/12/2001	US6245745 Bactericides and antiprotozoa agents
05/2001
05/31/2001	WO2001037845A1 Treatment of heart rhythm disturbances with n6-substituted-5'-(n-substituted) carboxamidoadenosines
05/31/2001	CA2392369A1 Treatment of heart rhythm disturbances with n6-substituted-5'-(n-substituted) carboxamidoadenosines
05/09/2001	EP1097937A1 N-acyl derivatives of the LL-E33288 antitumor antibiotics
05/03/2001	WO2001030795A1 Hygromycin derivatives
05/03/2001	WO2001030793A1 Hygromycin a prodrugs
05/03/2001	CA2389191A1 Hygromycin derivatives
05/03/2001	CA2389019A1 Hygromycin a prodrugs
04/2001
04/18/2001	EP1091970A1 Method for preparing aloin by extraction
04/18/2001	CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use
04/17/2001	CA2052323C Oligosaccharide conjugate vaccines
04/11/2001	EP1090022A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
04/04/2001	CN1290268A Nucleosides
03/2001
03/07/2001	CN1286692A Substances KF-1040 and process for producing same
03/07/2001	CN1286633A Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
02/2001
02/28/2001	EP1077984A1 2"-deoxy hygromycin derivatives
02/20/2001	US6191271 Synthetic divalent sLex containing polylactosamines and methods for use
02/14/2001	EP1075483A2 Hygromycin a derivatives
02/06/2001	US6184374 Targeted cytotoxic anthracycline analogs
01/2001
01/10/2001	EP1066305A2 Sucrose-n-alkyl-asparaginates, production and use thereof
12/2000
12/26/2000	CA2150671C Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections
12/14/2000	WO2000044763A3 Compositions for treating inflammatory response
12/05/2000	US6156737 Therapy for hepatitis b
11/2000
11/30/2000	WO2000071557A1 13-methyl-erythromycin derivatives
11/29/2000	EP1055682A1 Novel substances kf-1040 and process for producing the same
11/15/2000	EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/09/2000	WO2000066603A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
11/09/2000	WO2000066602A1 3-deoxy-desmycosin derivatives and process for their preparation
11/09/2000	WO2000066601A1 Method for preparing aloin by extraction
11/09/2000	CA2372977A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
11/09/2000	CA2368249A1 3-deoxy-desmycosin derivatives and process for their preparation
11/01/2000	CN1058011C 13-substituted milbemycin derivatives, and their use
10/2000
10/26/2000	WO2000063223A1 Novel 8a- and 9a-15-membered lactams
10/26/2000	CA2370273A1 Novel 8a- and 9a-15-membered lactams
10/26/2000	CA2369886A1 Macrolide antiinfective agents
10/24/2000	US6136809 Azolo triazines and pyrimidines
10/18/2000	CN1057443C Method for preparing antiviral medicinal compositions
09/2000
09/27/2000	CN1056849C Fungistatin derivate and its preparing method and its application in pharmacy
09/26/2000	US6124289 Azolo triazines and pyrimidines
09/19/2000	US6121005 Human growth arrest specific homeobox protein; transcription factor; for treatment of postangioplasty restenosis and other cardiovascular disorders; for screening cellular partners
09/06/2000	CN1265665A Benzimidazole derivatives
08/2000
08/30/2000	EP1030673A1 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
08/29/2000	CA2010164C Anthracycline immunoconjugates having a novel linker and methods for their production
08/10/2000	WO2000046231A1 Method for deprotecting oligonucleotides
08/09/2000	EP0539380B1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
08/03/2000	WO2000044763A2 Compositions for treating inflammatory response
08/03/2000	CA2361614E Compositions for treating inflammatory response
07/2000
07/05/2000	EP1015464A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
06/2000
06/28/2000	CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition
06/08/2000	WO2000032616A1 Hygromycin a derivatives as antibacterial agents
05/2000
05/30/2000	US6069250 Method and compositions for the synthesis of dioxolane nucleosides with β-configuration
05/11/2000	WO2000025799A1 β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HIV INFECTION
05/03/2000	CN1252000A Pharmaceutical compositions having appetite suppressant activity
04/2000
04/26/2000	EP0994890A2 Benzimidazole derivatives
04/04/2000	US6046313 Process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
03/2000
03/28/2000	CA2014472C N-acyl derivatives of the ll-e33288 antitumor antibiotics
02/2000
02/16/2000	EP0979826A1 Process for selective oxidation of primary alcohols of oligosaccharides
02/09/2000	EP0978570A2 Detecting mycobacterium tuberculosis by nucleic acid sequence amplification
02/02/2000	EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer
01/2000
01/26/2000	EP0973534A1 Pharmaceutical compositions having appetite suppressant activity
01/25/2000	US6017899 Non-reducing saccharide-forming enzyme, its preparation and uses
01/12/2000	EP0970074A1 METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH $g(b)-CONFIGURATION
01/05/2000	CN1240452A Fabric softening compositio
12/1999
12/29/1999	WO1999067265A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999	WO1999057125A3 Hygromycin a derivatives
12/29/1999	CA2335809A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/28/1999	CA1340866C Human c3b/c4b receptor (cr1)
12/28/1999	CA1340861C Cysteine-depleted muteins of biologically active proteins
12/14/1999	CA1340847C Adhesin antigens

1 2 3 4 5 6 7 8 9 10 11 12